Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amplified Sciences Inc
A prospective observational study to assess the impact of PanCystPro in patients with radiographically confirmed pancreatic cysts planned for Endoscopic Ultra Sound (EUS) Fine Needle Aspirate (FNA). Eligible subjects will be enrolled after signing the ICF. One pancreatic cyst sample will be sent to the Amplified lab for PanCystPro testing.
The impact of PanCystPro on clinical management intention will be assessed after the PanCystPro result has been received by the physician. One year after enrollment the actual clinical management the patient received will be assessed.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients 18 years of age or older
Cross sectional imaging studies demonstrating a pancreatic cyst at least 12 mm in size where fluid sampling can aid in patient's management
Written informed consent.
The patient will be undergoing EUS with anticipated FNA extraction as part of standard patient care.
You may not be if
Patients diagnosed with pancreatic cancer.
Pregnant or lactating females.
Patients with contraindications to moderate or deep procedural sedation (necessary for the conduct of the endoscopic ultrasound) like major cardiorespiratory illness.
Patients with contraindications to FNA of a pancreatic cyst like being on blood thinners.
